TIM-3 Antibody (344823) [Alexa Fluor® 700]

This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 2 confirmed species: Human, Mouse.

We have publications tested in 1 application: Flow Cytometry.

Showing Publications 1 - 4 of 4.

Publications using FAB2365N	Applications	Species
Mietz, J;Kaulfuss, M;Egli, L;Opitz, L;Münz, C;Chijioke, O; Human effector CD8+ T cells with an activated and exhausted-like phenotype control tumour growth in vivo in a humanized tumour model EBioMedicine 2024-07-09 [PMID: 38986249] (Flow Cytometry, Mouse)	Flow Cytometry	Mouse
Christiane Querfeld, Samantha Leung, Patricia L. Myskowski, Shane A. Curran, Debra A. Goldman, Glenn Heller et al. Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile Cancer Immunology Research 2018-08-01 [PMID: 29895574]
C Wang, MI Edilova, LE Wagar, S Mujib, M Singer, NF Bernard, T Croughs, MM Lederman, I Sereti, MA Fischl, E Kremmer, M Ostrowski, JP Routy, TH Watts Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy J. Immunol., 2017-12-08;0(0):. 2017-12-08 [PMID: 29222166] (Flow Cytometry, Human)	Flow Cytometry	Human
Lanteri M, Diamond M, Law J, Chew G, Wu S, Inglis H, Wong D, Busch M, Norris P, Ndhlovu L Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection. PLoS ONE, 2014-03-18;9(3):e92134. 2014-03-18 [PMID: 24642562] (Flow Cytometry, Human)	Flow Cytometry	Human

Array FAB2365N

• TIM-3 Antibodies
• TIM-3 Antibody Pair
• TIM-3 Lysate
• TIM-3 Proteins
• TIM-3 Proteins and Enzymes
• TIM-3 ELISAs